Addiction & Substance Use

As patients flock to CBD as a “natural alternative” to medications, the FDA continues to crack down on false claims.

How can we save more lives and prevent overdose deaths? Lloyd I Sederer, MD, a psychiatrist, expert in public health, and author provides insights.

A synthesis of quantitative reviews on the relationship between cannabis use and psychosis.

Should a patient at the end of her life have access to psilocybin, even if it’s illegal?

Psychiatrists face diagnostic puzzles almost every day. Find out how one clinician cracked a tough case.

Many patients with bipolar and other psychiatric disorders believe it is better to wait to address cigarette and other nicotine use. Here is why that is not necessarily the case.

Some commonly used drugs and narcotics have serious cardiovascular effects.

Black soldiers’ lack of access to opiate analgesics and antidiarrheals was typical, not exceptional, when considered within the broader scheme of Civil War medicine.

What digital therapeutic treatment for opioid use disorder will soon be available to complement psychiatric care?

Two recent papers look at the subtle and surprising links between smoking and pain in different parts of the body.

Research on a new kind of cannabis treatment prepares to move forward.

Are people with high "neuroticism-depression" likely to drink more than the average person when stressed? We may be getting closer to the answer.

Look at the big picture on cannabis: what harmful effects could it potentially have on your patients' brains?

1 in 6 people with opioid use disorder experience a new traumatic event every month, but no evidence-based treatment for trauma.

What are your thoughts about prescribing medical marijuana/cannabis to treat psychiatric disorders?

What are your feelings about the utility of cannabis in psychiatric practice?

With opioid use disorder, a tiny fraction of young patients are getting treatment, which would not be acceptable for any other medical condition.

The Department of Health and Human Services moves to reduce administrative procedural barriers to OUD treatment.

In an ADAPT-2 study, a combination of injectable naltrexone and oral bupropion showed promise for methamphetamine users.

Lessons from the opioid epidemic should be applied to cases of methamphetamine abuse.

An innovative program sends mental health first responders out onto the streets.

Tips for helping patients preserve their sobriety through the holiday season

Navigating the treatment options for comorbid schizophrenia and alcohol use

A drug developed to treat high blood pressure has unexpected benefits for patients with severe withdrawal symptoms.

Female emergency department patients with adverse childhood experiences were more likely to have substance use issues.